| Detected | Trial | Change |
|---|---|---|
| 2026-07-25 | NCT06990984 A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS) |
date change Primary completion pushed: 2026-09 -> 2027-06 |
| 2026-07-25 | NCT06990984 A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS) |
date change Completion pushed: 2026-09 -> 2027-09 |
| 2026-07-25 | NCT06644534 A Study to Assess TTI-0102 vs Placebo in MELAS Patients |
Trial completed |
| 2026-07-25 | NCT06644534 A Study to Assess TTI-0102 vs Placebo in MELAS Patients |
Enrollment reduced: 12 -> 9 participants |
| 2026-07-25 | NCT06644534 A Study to Assess TTI-0102 vs Placebo in MELAS Patients |
date change Primary completion moved earlier: 2026-04-30 -> 2026-01-12 |
| 2026-07-25 | NCT06644534 A Study to Assess TTI-0102 vs Placebo in MELAS Patients |
date change Completion moved earlier: 2026-06-30 -> 2026-01-12 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06990984 | A Dose-ranging Study of TTI-0102 in Adults and Children With Leigh Syndrome Spectrum (LSS) | Leigh Syndrome | Not Yet Recruiting |